Reduction in pulmonary vascular resistance with long-term epoprostenol (prostacyclin) therapy in primary pulmonary hypertension - McLaughlin,V.V.; Genthner,D.E.; Panella,M.M.; Rich,S. (N Engl J Med, 1998)